specific inhibitor AG 490 effectively inhibited the IL-6-induced STAT3, but not ERKs, mediates the IL-6-induced proliferation STAT3 activity and induced apoptosis, the blockade of the of renal cancer cells, ACHN and 769P.
Interleukin-6 (IL-6) is a cytokine with pleiotropic acmediating IL-6-induced proliferation and to investigate the tivities, including the induction of differentiation and the use of effective novel interventions to block the IL-6-induced regulation of growth in a cell-type dependent manner autocrine growth of renal cancer cells.
Methods. IL-6-induced proliferation and intracellular signal- [1] . IL-6 initiates its action by binding to its receptor, ing cascades were analyzed in four human renal cancer cell which is composed of two subunits: an 80-kD IL-6 bind- transducing component (gp130) [2, 3] . The binding of and extracellular signal-regulated kinases (ERKs), and the ef-IL-6 to its receptor induces the dimerization of gp130, fects of anti-IL-6 neutralizing antibody, Jak inhibitor AG 490, and MEK1 inhibitor PD 98059 were analyzed by Western blotthe activation of the gp130-associated protein tyrosine ting using phospho-specific antibodies. The DNA-binding ackinases of the Janus kinase families (Jak1, Jak2 and tivities of STATs were analyzed by EMSA. Apoptosis was deterTyk2) and the phosphorylation of gp130 at cytoplasmic mined by using nuclear staining and the TUNEL assay. Changes tyrosine residues [4] . These phosphotyrosines serve as in the apoptosis-related proteins, bcl-2, bcl-xL, and bax were docking sites for the SH2 domain containing proteins analyzed by Western blotting.
Results. IL-6 induced tyrosine phosphorylation and increased such as the signal transducers and activators of transcripthe DNA binding activity of STAT3 and, to a lesser extent, tion (STAT1 and STAT3) and the protein tyrosine phos-STAT1 in all cell lines except for Caki-1, which did not express phatase (SHP2), which themselves subsequently become the IL-6 receptor subunit gp130. ERKs were constitutively actyrosine phosphorylated [4, 5] .
tivated in all cell lines and the activation level was not up-regAfter tyrosine phosphorylation, STAT3 forms a homoulated further by exogenously added IL-6 nor down-regulated by anti-IL-6 neutralizing antibody. IL-6-induced STAT3 tyrodimer or a heterodimer with STAT1 and thereafter enters sine phosphorylation and DNA binding activity was inhibited the nucleus, where it regulates the expression of specific by treatment with Jak specific inhibitor AG 490; however, it genes. In addition to tyrosine phosphorylation, STAT3
was not affected by the MEK1 inhibitor PD 98059. Moreover, is serine phosphorylated at a single residue (Ser727) in treatment with AG 490 inhibited IL-6-induced proliferation response to IL-6 [6] . Although tyrosine phosphorylation of ACHN and 769P cells and induced apoptosis with the downregulation of bcl-2 and the up-regulation of bax.
can be activated by IL-6 independently of the tyrosine ville, MD, USA). All cells were maintained in RPMI-1640 supplemented 10% fetal bovine serum (FBS), 50 phosphorylation of gp130 [10] , while the stress-activated protein kinase p38 is also activated by IL-6 [11] . Al-IU/mL penicillin and 50 g/mL streptomycin at 37ЊC in a humidified atmosphere with 5% CO 2 . though STAT3 and ERKs have been reported to be major signaling pathways of IL-6, the molecules essential Reagents for the cell proliferation induced by IL-6 vary depending upon the cell type and the expression patterns of the Human recombinant IL-6 was purchased from Peprotech (Rocky Hill, NJ, USA) and used at 20 ng/mL. signaling molecules [5, 12, 13] . Moreover, ERKs also have been reported to play some role in the modulation Mouse monoclonal anti-human IL-6 neutralizing antibody (anti-IL-6 Ab) was obtained from R&D systems of STAT3 activity [7, 8, 14, 15] .
Despite extensive evaluations of many different treat-(Minneapolis, MN, USA). Jak inhibitor AG 490 and MEK1 inhibitor PD 98059 were from Calbiochem (La ment modalities, metastatic renal cell carcinoma (RCC) remains highly resistant to systemic therapy [16] . As a Jolla, CA, USA) and were solubilized in dimethylsulfoxide (DMSO) at 50 mmol/L, stored in the dark at result, the identification of new agents with better antitumor activity against metastases remains the highest pri-Ϫ70ЊC. Phorbol 12-myristate 13-acetate (PMA), which is a strong stimulator of ERKs, was from Calbiochem. ority in chemical studies of this refractory tumor. IL-6 has been suggested to function as an in vitro autocrine Rabbit polyclonal antibodies against STAT1, phosphospecific STAT1 at Tyr701 (p-STAT1), STAT3, phosphogrowth factor in RCC by demonstrating that primary RCC expressed IL-6, and that their in vitro growth was specific STAT3 at Tyr705 (p-STAT3), phospho-specific STAT5 at Tyr694 (p-STAT5), p38, phospho-specific p38 inhibited by an anti-IL-6 antibody [17, 18] . Patients with RCC often exhibit paraneoplastic syndrome, which inat Thr180/Tyr182 (p-p38), ERKs, phospho-specific ERKs at Thr202/Tyr204 (p-ERKs) were from New England cludes fever, leukocytosis, erythrocytosis, hypercalcemia and an elevation of acute phase reactants. IL-6 has been Biolabs (Beverly, MA, USA). Mouse monoclonal antibodies against STAT5, bcl-2, bcl-xL, bax, and mcl-1 were reported to be involved in the physiopathology of the paraneoplastic syndromes [19] . Furthermore, the majorfrom BD Transduction Laboratories, Inc. (Franklin Lake, NJ, USA). Mouse monoclonal antibody against ␤-actin ity of patients with metastatic RCC demonstrate increased levels of serum IL-6 while patients with detectable serum was from DAKO (Tokyo, Japan). IL-6 have poor survival [19] . These observations raise Determination of IL-6 secretion the possibility that pharmacological interventions to block IL-6-induced autocrine growth may have therapeutic
The cells were plated at 1 ϫ 10 4 cells/well in six-well plates in RPMI 1640 containing 10% FBS for 24 hours, potential in RCC. Unfortunately, the signaling mechanism involved in the IL-6-mediated growth of RCC reand then were washed with serum-free medium and cultured for an additional 24 hours in 1 mL of the serum mains to be elucidated.
In the present study, we characterized the signaling free medium. The medium was collected and clarified by centrifugation at 3000 ϫ g. The levels of IL-6 in the cascades mediating the IL-6-induced proliferation in renal cancer cells and investigated a novel pharmacological supernatants were analyzed by enzyme-linked immunosorbent assay (ELISA) using the HS human IL-6 immuintervention to block IL-6-induced growth. Our results demonstrated that the response of renal cancer cells to noassay kit (R&D Systems). IL-6 is most likely mediated by STAT3, but not ERKs.
RNA extraction and RT-PCR analysis for Moreover, ERKs were constitutively activated indepen-IL-6 receptor gp80 and gp130 subunits dently of IL-6 stimulation. In addition, ERK activity was not essential for modulation of STAT3 tyrosine phosFor RT-PCR, total RNA was isolated from 1 ϫ 10 7 cells using Trizol according to the manufacturer's instructions phorylation and DNA-binding activity. We also demonstrated that Jak inhibitor AG 490 effectively inhibited (Gibco Life Technology, Rockville, MD, USA). One microgram RNA was reverse transcribed by Molony muthe IL-6-induced activation of STAT3 without any effect on ERKs activity and induced apoptosis in renal cancer rine leukemia virus (MMLV) reverse transcriptase (Boehringer Mannheim, Mannheim, Germany) with hexamer cells. Based on these findings, we postulate that a disruption of the IL-6-mediated signals to STAT3 is potentially random primer. For polymerase chain reaction (PCR), 2 L cDNA was amplified using each gene specific primuseful as a novel therapeutic approach to RCC.
ers in a total volume of 50 L using 2 U Taq polymerase (Boehringer Mannheim). were separated on a non-denaturing 4% polyacrylamide as a downstream primer for gp80, and 5Ј-TGA AGG gel in 0.5% TBE. Thereafter, the gels were dried and TCG GAG TCA ACG GAT TTG GT-3Ј as an upstream autoradiographed. primer and 5Ј-CAT GTG GGC CAT GAG GTC CAC CAC-3Ј as a downstream primer for GAPDH. The gp130, Determination of cell viability gp80 and GAPDH product sizes were 720 bp, 768 bp
The effects of IL-6, anti-IL-6 Ab and AG 490 on cell and 983 bp, respectively [20] .
viability of renal cancer cells were determined by using Western blotting crystal violet staining as described previously [21] . In brief, the cells were plated into a flat-bottom 96-well For analyses of intracellular signals by IL-6 in renal plates at 1 ϫ 10 4 cells/200 L /well in triplicate in RPMIcancer cells, the cells were starved for 24 hours in serum-1640 with 10% FBS. Twenty-four hours later, the mefree RPMI-1640 and stimulated with IL-6 for the indidium was changed to serum-free medium containing the cated time. The cells were put on ice and rinsed with indicated reagents and incubated for the indicated time. ice-cold phosphate-buffered-saline (PBS) containing 100
After incubation, the plates were washed and cell viabilmol/L Na 3 VO 4 , and lysed with cell lysis buffer [20 mmol/L ity was determined by staining the plates with 0.2% crysTris pH 7.4, 150 mmol/L NaCl, 2 mmol/L ethylenediaminetal violet (in 2% ethanol). tetraacetic acid (EDTA), 1% NP-40, 50 mmol/L NaF, 10 g/mL aprotinin, 10 g/mL leupeptin, 1 mmol/L pheNuclear staining nylmethylsulfonyl fluoride (PMSF), 1 mmol/L Na 3 VO 4 ].
The cells were fixed with 4% paraformaldehyde for 30 The extracts were clarified by centrifugation at 12,000 minutes at room temperature and stained with 1 mmol/L r.p.m for five minutes. Lysates containing equal amounts Hoechst 33258 (Sigma, St. Louis, MO, USA) for 10 minof proteins were resolved by electrophoresis on 12% utes at 37ЊC. The morphology was observed under a sodium dodecyl sulfate-polyacrylamide gel electrophofluorescence microscope at a 365-nm-wavelength excitaresis (SDS-PAGE) and then transferred to nitrocellulose tion light. membrane (Bio-Rad Laboratory, Hercules, CA, USA). The membranes were blocked with Tris-buffered saline TUNEL analysis (TBS) containing 5% nonfat milk before incubation with DNA fragmentation was detected using the TUNEL primary antibodies. Immunoreactive bands were visualtechnique as described previously [22] . In brief, 1 ϫ 10 6 ized with the amplified alkaline phosphatase system accells were fixed in 1% paraformaldehyde, permeabilized cording to the manufacturer's instructions (Bio-Rad).
in 70% ethanol, and stored at Ϫ20ЊC. Breaks at 3Ј-OH For analyzing the effect of AG 490 and PD 98059 on DNA were detected by the TUNEL technique using the the intracellular signals, the cells were pretreated with Apotag Plus Fluorescein (FITC) kit (Oncor, Gaithersserial dilutions of AG 490 (for 16 hours) or PD 98059 burg, MD, USA) according to the supplier's instructions. (for one hour) prior to stimulation with IL-6. For analyz-FITC-labeled cells were counterstained with propidium ing the changes in the expression levels of apoptosisiodide (PI; Sigma) and analyzed by flow cytometry using related proteins, the cells were incubated with IL-6 in EPICS ALTRA flow cytometer (Beckman Coulter, Fulthe presence of 100 mol/L AG 490 for the indicated lerton, CA, USA). time. The cell lysates were prepared, and Western blotting was performed in the same manner.
Quantification of the immunoreactive bands and statistical analysis Electrophoretic mobility shift assay (EMSA)
The relative density of immunoreactive bands of apoNuclear extracts were prepared in hypertonic buffer ptosis-related proteins on Western blotting was calcu-[20 mmol/L HEPES pH 7.9, 420 mmol/L NaCl, 1 mmol/L lated using the Image 1.52 program (NIH, Bethesda, MD, EDTA, 1 mmol/L egtazic acid (EGTA), 20% glycerol, USA). The unpaired t test was used to determine statisti-20 mmol/L NaF, 1 mmol/L Na 3 VO 4 , 1 mmol/L Na 4 P 2 O 7 , cal differences. A P value of less than 0.05 was considered 1 mmol/L dithiothreitol (DTT), 0.5 mmol/L PMSF, 1 to indicate statistical significance. g/mL aprotinin, 1 g/mL leupeptin]. Twenty micrograms of the supernatants were incubated with 2 g poly dI-dC RESULTS (Amersham Pharmacia Biotech, Buckinghamshire, UK)
Production of IL-6 and expression of IL-6 receptor with double-strand oligonucleotides for the consensus subunits in renal cancer cells binding of sis-inducible-element (SIE; 5Ј-GTG CAT TTC CCG TAA ATC TTG TCT AGA-3Ј) labeled with [␥- 32 
P]
First, the production of IL-6 into the culture medium and the expression of IL-6 receptor subunits (gp80 and dATP by T4 polynucleotide kinase (New England Bio-gp130) were confirmed in renal cancer cells. Basal IL-6 secretion levels were determined using ELISA. Although all cell lines exhibited detectable basal production of IL-6 (35.3 Ϯ 13.8 pg/mL in Caki-1, 16.3 Ϯ 9.3 pg/mL in ACHN, 4.2 Ϯ 2.0 pg/mL in 769P, and 219 Ϯ 37 pg/mL in A498, respectively), the levels of IL-6 production varied widely depending upon the cell type (Fig. 1A) . Expression of mRNA for gp80 and gp130 was determined by the RT-PCR methods. The specific product for gp80 subunit (768 bp) was observed in all cell lines, whereas gp130 (720 bp) was expressed in ACHN, 769P and A498, but not in Caki-1 (Fig. 1B) .
Effect of exogenously added IL-6 and anti-IL-6 Ab on the proliferation of renal cancer cells
The effects of exogenously added IL-6 and anti-IL-6 Ab on the proliferation of renal cancer cells were assessed by crystal violet staining. According to the manufacturer's specifications, 1.5 g/mL of the anti-IL-6 Ab almost completely neutralized the biological activity due to 20 ng/mL IL-6. Incubation with IL-6 increased ACHN and 769P cells growth by 154.6 Ϯ 6.7% and 122.8 Ϯ 7.1%, respectively, after 96 hours in comparison to the untreated cells (P Ͻ 0.05; Fig. 1C ). Moreover, preincubation with anti-IL6 Ab significantly inhibited IL-6-induced cell proliferation of ACHN and 769P cells (P Ͻ 0.05; Fig. 1C ). Although no significant proliferation by exogenously added IL-6 was observed in A498 cells, anti-IL-6 Ab significantly inhibited proliferation compared with untreated cells (P Ͻ 0.05; Fig. 1C ). In Caki-1, which did not express gp130 mRNA, IL-6 and anti-IL-6 Ab had no effect on the proliferation (Fig. 1C) .
Analyses of intracellular signals of IL-6 in renal cancer cells
The intracellular signaling pathways of IL-6 in renal cancer cells were analyzed by Western blotting using phospho-specific antibodies, which only detect the activated status. First, the effect of IL-6 on the tyrosine phosphorylation levels of STAT1, STAT3 and STAT5 (STAT1 at Tyr701, STAT3 at Tyr705, and STAT5 at Tyr694, respectively) was examined. To assess the phosphorylation levels of STAT proteins, starved cells were either left unstimulated or were stimulated with IL-6 for 15 minutes. Total cell extracts were prepared and and STAT5 proteins were present in all cell lines and determined using ELISA. Cells were seeded at equal densities (1 ϫ 10 4 cells/well) in 6-well plates. Next the cells were cultured for 24 hours the expression levels were not affected by IL-6 ( Fig. 2A) .
in serum free medium and the supernatants were analyzed with ELISA.
IL-6 induced comparable tyrosine phosphorylation of
The results represent the mean Ϯ SD of three separate experiments.
(B) RT-PCR analysis for the expression of the IL-6 receptor (gp80) and gp130 mRNA in renal cancer cells. The gp130, gp80 and GAPDH product sizes were 720 bp, 768 bp and 983 bp, respectively. GAPDH was used as an internal control. (C ) Cell proliferation in response to IL-6. Cells were incubated in the presence or absence of 20 ng/mL IL-6 viability was determined by crystal violet staining. Results represent the with or without 1.5 g/mL anti-human IL-6 antibody (Ab) for 96 hours.
mean Ϯ SD of three separate experiments. *P Ͻ 0.05 compared with Symbols are: (ᮀ) untreated; () IL-6; ( ) IL-6 ϩ anti-IL-6 Ab. Cell untreated cells. **P Ͻ 0.05 compared with the cells treated with IL-6. STAT3 and, to a lesser extent, STAT1 in all cell lines STAT1, STAT3 and ERKs in response to IL-6, ACHN cells were stimulated with IL-6 for 15 to 60 minutes and except for Caki-1, which did not express gp130 ( Fig. 2A) . The amount of phosphorylated STAT1 seemed to be far the phosphorylation levels were analyzed by Western blotting. The transient tyrosine phosphorylation of STAT3 less than that of phosphorylated STAT3 because the exposure time to detection reagents required to visualize and, to a lesser extent, STAT1 was observed within 15 minutes upon IL-6 stimulation in ACHN cells and rethe immunoreactive bands of phosphorylated STAT1 is much longer than phosphorylated STAT3. IL-6 did not turned to near basal level within approximately 60 minutes, whereas the phosphorylation level of ERKs showed induce tyrosine phosphorylation of STAT5 in all cell lines ( Fig. 2A) . no changes from the unstimulated level at any periods (Fig. 2D) . The phosphorylation of STAT5 and p38 was To determine whether IL-6 activated the ERKs and p38 cascades, their activation status was assessed by not observed at any period (data not shown). The same results also were obtained for 769P cells (data not shown). Western blotting using antibodies that specifically recognize the dually phosphorylated status (ERKs at Thr202/ Endogenous IL-6 produced by renal cancer cells was Tyr204 and p38 at Thr180/Tyr182, respectively). In all not responsible for the constitutive activation of ERKs cell lines, total ERKs and p38 were expressed at comparable levels, which were not affected by IL-6 (Fig. 2B) .
Because ERKs have been shown to be a major mediaInterestingly, ERKs were constitutively activated in all tor of IL-6 signaling [5, 12] and renal cancer cells secreted cell lines, which were not further up-regulated by stimudetectable levels of IL-6 into a culture medium (Fig. 1A) , lation with exogenous IL-6 (Fig. 2B) . A strong stimulator we questioned whether endogenous IL-6 produced by for ERKs phosphorylation, PMA, increased ERK phosrenal cancer cells might be responsible for the constituphorylation in Caki-1 and 769P cells, which strongly suptive activation of ERKs. We examined whether the neuport our results, indicating that IL-6 did not up-regulate tralization of endogenous IL-6 activity might lead to a ERK phosphorylation (Fig. 2C) . On the other hand, p38 decrease in the phosphorylation levels of ERKs. The was not activated by IL-6 in any of the cell lines (Fig. 2B) .
starved ACHN and 769P cells were untreated, stimulated with IL-6 for 15 minutes, cultured for 24 hours with antiFurthermore, to study the phosphorylation kinetics of cording to the cell type and activation status [7, 8, 14, 15] . ERKs have been reported to potentiate the STAT3 activity through serine phosphorylation [8], while inhibiting the STAT3 activity upstream from tyrosine phosphorylation [15] . Since the ERKs were constitutively activated in all cell lines in our experiments, we speculated that ERKs was involved to some degree in the modulation of STAT3 activity. To examine whether the inhibition of the ERK activity by PD 98059, which is a specific trations of PD 98059 one hour prior to stimulation with IL-6. PD 98059 inhibited the constitutively activated ERKs at 25 mol/L in both cell lines, whereas it did IL-6 Ab, or cultured for 24 hours with anti-IL-6 Ab prior not affect the tyrosine phosphorylation levels of STAT3 to stimulation with IL-6, and then the phosphorylation induced by IL-6 even at 100 mol/L (Fig. 5) . These levels of ERKs were analyzed by Western blotting. In results indicate that the ERK activity is not essential both cell lines, the levels of ERKs phosphorylation were for the modulation of STAT3 activation at the tyrosine not down-regulated by treating the cells with anti-IL-6 phosphorylation level. Ab nor up-regulated by any subsequent stimulation with exogenous IL-6 (Fig. 3) . The same results also were seen IL-6-induced STATs-DNA binding activity is in Caki-1 and A498 cells (data not shown). These results inhibited by AG 490, but not by PD98059 indicate that constitutive ERK phosphorylation does not
In addition to tyrosine phosphorylation, we examined appear to be due to the endogenous IL-6 produced by whether IL-6 increases the STATs-DNA binding activity renal cancer cells. and whether AG 490 or PD 98059 suppresses the DNA The Jak-specific inhibitor AG 490 attenuated binding activity by EMSA using a 32 P-labeled SIE probe, IL-6-induced tyrosine phosphorylation of STAT3, which binds both activated STAT1 and STAT3 with a but not constitutive phosphorylation of ERKs high affinity [23, 24] . The stimulation of ACHN and Interleukin-6 leads to the homodimerization of gp130, 769P cells with IL-6 resulted in the rapid induction of a which results in the activation of gp130-associated Jak1, STATs-DNA complex that binds the SIE oligonucleoJak2 and Tyk2. Subsequently, gp130 is phosphorylated tides (Fig. 6) . The IL-6-induced STATs-DNA binding on tyrosine, and the phosphorylated molecule recruits activity was markedly inhibited by AG 490, but not PD SHP2 and STAT3 [4, 5] . To investigate the involvement 98059, and this finding closely correlated with that of of Jak kinase in IL-6-mediated signaling cascades in renal the tyrosine phosphorylation level (Fig. 6 ). These results cancer cells, we examined whether treatment with the indicate that the ERK activity is not involved in the Jak-specific inhibitor AG 490 attenuates the phosphorymodulation of the STAT3 activity at the nuclear translation levels of STAT3 and ERKs. ACHN and 769P cells location level. were exposed to various concentrations of AG 490 16 hours prior to stimulation with IL-6. Preincubation with AG 490 suppressed the IL-6-induced proliferation of AG 490 resulted in the inhibition of the IL-6-induced renal cancer cells tyrosine phosphorylation of STAT3 at 25 mol/L in Previous results indicated that IL-6 mainly activates ACHN cells and at 100 mol/L in 769P cells (upper STAT3, while Jak inhibitor AG 490 effectively inhibits panels, Fig. 4 ). On the other hand, the constitutive phosthe IL-6-induced STAT3 tyrosine phosphorylation and phorylation of ERKs was not suppressed by AG 490, DNA binding activity in ACHN and 769P cells. To study even at high concentrations (100 mol/L) in both cell the functional consequences following the inhibition of lines (lower panels, Fig. 4 ). These results indicate that IL-6 signaling by Jak inhibitor, the effect of AG 490 on Jak kinase is essential for the IL-6-induced activation of IL-6-induced proliferation of renal cancer cells was tested STAT3, but not for the constitutive activation of ERKs in on ACHN and 769P cells that had been treated with IL-6 renal cancer cells.
in the presence or absence of AG 490 at serial concentraInhibition of constitutively activated ERKs by the tions for 96 hours. The proliferation of both cell lines MEK1 inhibitor PD 98059 did not modulate the was significantly suppressed following AG 490 treatment IL-6-induced tyrosine phosphorylation of STAT3 in a dose dependent manner (Fig. 7) . The proliferation of ACHN cells was significantly suppressed by AG 490 The functional significance of ERKs in the modulation of the STAT3 activity has been reported to vary acat a concentration Ն1 mol/L, with IC 50 ϭ 0.5 mol/L and 769P cells also was suppressed at a concentration Ն1.0 mol/L, with an IC 50 ϭ 3.5 mol/L. The toxic effects from the solvent used to dissolve AG 490 could be excluded since the cells incubated with the highest concentration of DMSO, which was equivalent to 100 mol/L AG 490, showed no significant growth inhibition (data not shown). To examine any other effects of AG 490, the effects of AG 490 on the proliferation of 769P and ACHN cells were examined without IL-6 stimulation, which resulted in significant growth suppression (data not shown). However, the concentration of AG 490 required to suppress proliferation of Caki-1 cells also is much higher than to suppress the IL-6-driven proliferation of 769P AG 490 induced apoptosis in renal cancer cells and ACHN cells (IC 50 value ϭ 30.0 mol/L in Caki-1 cells). Based on these results, the spontaneous and IL-6-Activated STAT3 signaling has been shown to prevent induced growth of renal cancer cells seems to be meapoptosis [13, 26, 27] , and to determine whether the indiated by at least partly distinct pathways with different hibition of IL-6-induced signals by AG 490 may lead to sensitivities to AG 490. Similar results indicating different apoptotic cell death, nuclear staining was done using a sensitivities to AG 490 between cytokine-driven growth Hoechst 33258 and a flow cytometric TUNEL assay, both and spontaneous growth have been reported in another of which are useful methods for detecting apoptosis. ACHN cells were either untreated or incubated with IL-6 study [25] .
in the absence or the presence of 100 mol/L AG 490 for 96 hours and then stained with the DNA-specific fluorescent dye Hoechst 33258 for morphological examination. The nuclei of the cells treated with IL-6 in the presence of AG 490 appeared lobated and severely fragmented and contained highly condensed chromatin (Fig. 8A) , which are characteristic findings of apoptosis. Furthermore, AG 490-induced apoptosis also was confirmed by a flow cytometric TUNEL assay. The untreated cells and cells cultured with IL-6 in the absence of AG490 showed apoptosis in only 0.8% and 0.4% of cells, respectively, whereas the cells cultured with IL-6 in the presence of 100 mol/L AG 490 showed apoptosis in 34.9% of cells (Fig. 8B) . These apoptosis-inducing effects were observed in 769P cells as well (data not shown).
Changes in apoptosis-related proteins levels in AG 490 induced apoptosis
To further clarify the mechanisms underlying the AG 490-induced apoptosis of renal cancer cells, we examined whether AG 490 induces apoptosis by modulating the expression of apoptosis-related proteins, bcl-2, bcl-xL, mcl-1, and bax by Western blotting. ACHN cells were incubated with IL-6 in the presence of 100 mol/L AG 490 for the indicated times and thereafter were subjected to Western blotting. Although the bcl-2 and bax proteins were expressed at basal levels in ACHN, the expression of bcl-xL protein was very modest (Fig. 9 ) and mcl-1 could not be detected (data not shown). The inhibition of the Jak kinase activity by AG 490 resulted in the down-regulation of bcl-2 by 66.9% and the up-regulation of bax by 153.5% following 96 hours of treatment compared with the basal levels (Fig. 9) . On the other hand, the expression of bcl-xL did not change (Fig. 9) .
DISCUSSION
Although IL-6 has been shown to play an important role in the proliferation of RCC [17] [18] [19] , the molecular basis for IL-6-mediated signaling cascades has not been previously investigated. To the best of our knowledge, this is the first report that characterized the signaling cascades mediating the IL-6-induced proliferation of renal cancer cells.
The present study first confirms the role of IL-6 in the proliferation of renal cancer cells. In our experiments, a significant IL-6-induced proliferation was observed in dition suggests that the proliferation of A498 cells depends at least in part upon IL-6. In our additional experi- in A498 cells up to 20 ng/mL. The lack of gp130 mRNA expression, which is essential for IL-6-mediated signaling [2, 3] , could account for the unresponsiveness of Caki-1 to IL-6 and anti-IL-6 Ab. From these results, we confirmed that IL-6 acts as an autocrine or paracrine growth factor in renal cancer cells and these findings closely correlate with those of previous studies [17, 18] .
To investigate which molecules were involved in the IL-6-mediated proliferation of renal cancer cells, we took into consideration that IL-6 acts as a growth factor for a variety of malignant tumors, in addition to RCC [12, 13, 20, 29] . Although STAT3 and ERKs have been reported to be major signaling pathways of IL-6 and recent studies showed that STAT5 and stress-activated protein kinase p38 are also activated by IL-6, the cascades mediating IL-6-induced growth vary depending upon the cell type. For example, in a B9 murine IL-6-dependent hybridoma cell line and some human multiple myeloma cells, the activation of STAT3 occurs independently of the proliferative response to IL-6, and their growth depends upon the activation of ERKs [12] . On the other hand, IL-6 stimulates prostate cancer cell growth accompanied by the activation of the STAT3 signaling pathway [29] . Moreover, STAT3 signaling is essential for the survival of IL-6-dependent human myeloma cell line, U266 cells [13] . In our experiments, IL-6 induced tyrosine phosphorylation and DNA binding activity of STAT3 and, to a lesser extent, STAT1 in all cell lines except for Caki-1 without any expression of gp130. We cannot completely exclude the possibility that STAT1 might contribute to IL-6-driven proliferation. However, recent studies revealed that STAT1 actually has tumor of activated STAT1 can be overcome by the simultaneous activation of STAT3, which resulted in cell proliferation. The activation of STAT3 was attenuated by treatments, the proliferation of A498 cells was significantly ment with Jak inhibitor AG490 in ACHN and 769P cells, stimulated by exogenous IL-6 at a tenfold higher concenwhich proliferated by IL-6. The IL-6-induced proliferatration (200.0 ng/mL). According to various reports, IL-6 tion of ACHN and 769P cells was significantly inhibited exerts its biological activity in the concentration range by AG 490. Although STAT5 and p38 were expressed of 0.1 ng/mL to 100.0 ng/mL, which is considered to be a in all cells, their activation was not observed after stimuphysiological range [12, 15, 20, 28] . In fact, the serum IL-6 lation with IL-6. On the other hand, ERKs were constitulevels in patients with RCC have been reported between tively activated in all cell lines, even in Caki-1 cells, which 1 pg/mL to 1850 pg/mL [19] . As a result, the exogenous did not express gp130, and the activation level of ERKs IL-6-driven proliferation of A498 cells seems to be obwas not further up-regulated by exogenously added IL-6 served only under non-physiological conditions. A possinor down-regulated by anti-IL-6 Ab. Furthermore, the ble explanation for IL-6-induced STAT3 activation withinhibition of IL-6-mediated signal at the Jak kinase level out a proliferative response is that activation level of by AG 490 did not decrease the degree of ERK phos-STAT3 might be insufficient for the IL-6-driven proliferphorylation. Based on these findings, we conclude that ation up to 20 ng/mL or that IL-6-induced activation of STAT3, but not ERKs, mediates the IL-6-induced proliferation of renal cancer cells. STAT3 might be independent of the growth stimulation The exact mechanism underlying the constitutive actibecause of its absence of any effects on other tyrosine kinases such as Lck, Lyn, Btk, Syk, or Src [36] . Recent vation of ERKs in RCC is not known at present. The constitutive activation of ERKs has been shown to occur in studies revealed that AG 490 inhibit Jak1 and Jak3, in addition to Jak2, all of which are closely related members the majority of RCC and the levels of activated ERKs increased with increasing tumor grade and stage [33] .
of the Jak kinase families [37, 38] . However, no other additional AG 490-inhibited kinases have been reported ERKs are activated by a variety of mitogens such as epidermal growth factor (EGF) and transforming growth and AG 490 does not inhibit growth of Jak-negative Jurkat cells and Bcr-Abl fusion protein positive K562 factor (TGF)-␣ [34] . In addition to IL-6, EGF and TGF-␣ stimulate the growth of renal cancer cell lines in an autocells, and these findings strongly support the specificity of AG 490 to Jak kinase [37, 39] . We cannot completely crine manner [35] . We speculate that such growth factors produced by renal cancer cells may be, at least in part, exclude the possibility that AG 490 inhibits signaling cascades other than STAT3. Because AG 490 is likely responsible for the constitutive activation of ERKs.
Studies have revealed that ERKs were involved in the to be a Jak specific inhibitor, it may inhibit any other several downstream molecules that are associated with modulation of STAT3 activity [7, 8, 14, 15] . ERKs were reported to potentiate STAT3 activity through serine Jak kinase. In addition to STAT3, to date several signaling pathways are inhibited by AG 490, such as STAT5 phosphorylation [8] , as well as to inhibit the STAT3 activity upstream of tyrosine phosphorylation [15] . The reland ERKs [37, 38] . However, we showed that STAT5 is not activated in either basal or IL-6-stimulated condiative intensity of ERKs activity determines the modulation of the STAT3 activity [7] . Although ERKs were tions and that constitutively activated ERKs were not inhibited by AG 490 even at 100 mol/L. Thus, the possiconstitutively activated independently of IL-6, we speculated ERKs plays some role in the modulation of the bility that AG 490 might inhibit additional signals, at least for STAT5 and ERKs, can be excluded. In addition, STAT3 activity. We therefore investigated the role of ERKs in relation to the modulation of STAT3 activity at the effects of AG 490 on the spontaneous growth of renal cancer cells resulted in significant growth suppression. the level of tyrosine phosphorylation and DNA binding activity by using the MEK1 inhibitor PD 98059. Since the However, the concentration required to suppress the spontaneous growth was much higher than that required inhibition of the ERK activity by PD 98059 did not modulate the tyrosine phosphorylation or the DNA binding to suppress the IL-6-induced growth. Similar results indicating different sensitivities to AG 490 between cytoactivity of STAT3 in renal cancer cells, we conclude that the ERK activity is not essential for the modulation of kine-driven growth and spontaneous growth were reported in another study [25] . We speculate that the difference the IL-6-induced STAT3 activation.
The ERK and STAT3 signaling pathways have been between the concentrations of AG 490 required to suppress spontaneous growth and IL-6-driven growth is due shown to be essential for IL-6-mediated cell proliferation in other cells [5] . The ERK activation was shown to to the difference between the basal and IL-6-induced Jak kinase activity. Based on these findings, we believe be essential for mitogenic signals, while, on the other hand, the STAT3 activation has been shown to be involved in that AG 490-induced apoptosis is mediated, at least in part, by an inhibition of STAT3 activity. the anti-apoptotic signals [5] . Accumulating evidence suggests that the STAT3-mediated inhibition of apoptosis Recent studies showed that AG 490 has been shown to block activation of STAT3 and growth of various cancer may be caused by the regulation of apoptotic regulatory proteins, such as anti-apoptotic protein bcl-2 and bcl-xL cells by the induction of apoptosis [13, 25, 29] . Therefore, we investigated whether the inhibition of IL-6-induced [27]. Moreover, STAT3 regulates the transcription from the bcl-x promoter [13], and cells transformed by consti-STAT3 activation by the Jak inhibitor AG 490 subsequently leads to an inhibition of cell proliferation by tutively activated STAT3 also have elevated levels of bcl-xL mRNA [26] . Because we demonstrated that STAT3, induction of apoptosis with a modulation of anti-apoptotic proteins bcl-2, bcl-XL, mcl-1 and the pro-apoptotic but not ERKs, mediated the IL-6-induced proliferation of renal cancer cells, we speculated IL-6 might induce protein bax. In line with previous reports, AG 490 inhibited both the IL-6-induced STAT3 activation and cell proliferation by preventing apoptosis via the STAT3 signaling pathway.
IL-6-triggered proliferation of ACHN and 769P cells by the induction of apoptosis with a down-regulation of AG 490, a newly identified Jak inhibitor, was first shown to inhibit active DNA synthesis and it blocks the growth bcl-2 and up-regulation of bax. Whereas the changes in their expressions by AG 490 were very modest, other of recurrent pre-B-cell acute lymphoblastic leukemia cells in which Jak2 is constitutively activated both in vitro apoptosis-related proteins may be involved. The antiapoptotic proteins bcl-2, bcl-xL, and mcl-1 have all been and in vivo by inducing apoptosis [36] . The efficacy of AG 490 in vivo is accompanied by a complete absence shown to be capable of binding to pro-apoptotic protein bax and suppressing bax-induced apoptosis [40] . Among of toxicity to normal blood cells [36] . It has been demonstrated that AG 490 is not a general kinase inhibitor the bcl-2 family proteins, bcl-2 is frequently expressed remains the mainstay of therapy and metastatic RCC
